A Double-Blind, Placebo-Controlled, Crossover Study of Osmotic Release Oral System Methylphenidate in Adults With ADHD With Assessment of Oppositional and Emotional Dimensions of the Disorder
The DOI matches its Crossref record.
Abstract
BACKGROUND: The realization that attention-deficit/hyperactivity disorder (ADHD) often persists into adulthood has led to increased frequency of diagnosis and treatment in adults. Osmotic release oral system (OROS) methylpheni-date is a long-acting stimulant demonstrated to be effective in the treatment of children and adolescents with ADHD. METHOD: Forty-seven adults entered and 41 completed this double-blind, placebo-controlled, crossover trial of OROS methylphenidate. Each double-blind arm lasted 4 weeks; data were collected from August 2004 through December 2005. Subjects met both DSM-IV-TR and Utah Criteria for ADHD in adults. Outcome measures included the Wender-Reimherr Adult Attention Deficit Disorder Scale (WRAADDS), the adult ADHD-Rating Scale (ADHD-RS), and the Clinical Global Impressions-Improvement scale (CGI-I). At baseline, subjects were categorized as having significant emotional symptoms with the WRAADDS and/or significant oppositional-defiant symptoms using a self-report scale assessing the DSM-IV criteria for oppositional defiant disorder. RESULTS: 17% of the sample (N = 8) had ADHD alone, 38% (N = 18) had ADHD plus significant emotional symptoms, and 40% (N = 19) had ADHD with both significant emotional and oppositional symptoms. At a mean +/- SD dose of 64.0 +/- 23.3 (0.75 mg/kg), OROS methylphenidate proved superior to placebo for all clinical measures: total WRAADDS score decrease of 42% versus 13%, respectively, p < .001 and total ADHD-RS score decrease of 41% versus 14%, respectively, p = .003, plus the subscales addressing inattention, hyperactivity/ impulsivity, and emotional dysregulation. CONCLUSIONS: OROS methylphenidate proved effective in treating adult ADHD. ADHD alone was relatively uncommon. Over 80% of our patients had ADHD with a combination of emotional and/or oppositional symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This has been supported to some extent by recent clinic-based studies reporting impairing emotion dysregulation in between 34-70% of adults with ADHD, although population based studies are needed (69-73)–Table 1.”
From Emotion Dysregulation in Attention Deficit Hyperactivity Disorder (2014) · cites this paper as [72]
In the citing paper
“The paucity of empirical support for stimulant effects on emotional lability stands in stark contrast with the numerous, randomized clinical trials demonstrating stimulant’s short term efficacy on the diagnostic symptoms of ADHD [32, 33].”
From Using Stimulants to Treat ADHD-Related Emotional Lability (2014) · cites this paper as [33]
In the citing paper
“Recent trials in ADHD patients indicate that besides ADHD symptoms, mood instability improves with both stimulant treatment and atomoxetine [234,235].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [234]
In the citing paper
“Symptoms such as demoralisation and low self-esteem following a life with ADHD, and mood instability, improve with stimulant treatment alone [234].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [234]
Citations
Cites
Still being checked.
Cited by
Items 101–177 of 177
Williamson, T. M., Campbell, T. S., Telfer, J. A., & Rash, J. A. (2017) · Obesity Surgery · doi:10.1007/s11695-017-3037-3 · Cited by 20
Victor, M. M., Grevet, E. H., Salgado, C. A. I., Silva, K. L., Sousa, N. O., Karam, R. G., Vitola, E. S., Picon, F. A., Zeni, G. D., Contini, V., et al. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181c00b1e · Cited by 20
Williams, E. D., Reimherr, F. W., Marchant, B. K., Strong, R. E., Halls, C., Soni, P., Gale, P. D., & Robison, R. J. (2010) · Annals of Clinical Psychiatry · doi:10.1177/104012371002200203 · Cited by 26
Self-citationVictor, M. M., Rovaris, D. L., Salgado, C. A. I., Silva, K. L., Karam, R. G., Vitola, E. S., Picon, F. A., Contini, V., Guimarães-da-Silva, P. O., Blaya‐Rocha, P., et al. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000091 · Cited by 25
Moss, S. B. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s4101 · Cited by 21
Murphy, D., Glaser, K., Hayward, H., Eklund, H., Cadman, T., Findon, J., Woodhouse, E., Ashwood, K., Beecham, J., Bolton, P., et al. (2018) · Programme Grants for Applied Research · doi:10.3310/pgfar06020 · Cited by 18
The use of lisdexamfetamine dimesylate for the treatment of ADHD
Childress, A. C., & Sallee, F. R. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.175 · Cited by 18
Pharmacological treatment of adult ADHD
Bitter, I., Angyalosi, A., & Czobor, P. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328356f87f · Cited by 21
Linderkamp, F., & Lauth, G. W. (2011) · Verhaltenstherapie · doi:10.1159/000332429 · Cited by 19
Dysfonctionnements émotionnels dans le trouble déficit d’attention/hyperactivité (TDAH)
Purper‐Ouakil, D., & Franc, N. (2011) · Archives de Pédiatrie · doi:10.1016/j.arcped.2011.03.003 · Cited by 22
The Impact of Emotional Lability Symptoms During Childhood in Adults With ADHD
Gisbert, L., Richarte, V., Corrales, M., Ibáñez, P., Bosch, R., Casas, M., & Ramos‐Quiroga, J. A. (2017) · Journal of Attention Disorders · doi:10.1177/1087054717719534 · Cited by 18
Psychometric Properties of the Self-Report Wender-Reimherr Adult Attention Deficit Disorder Scale
Marchant, B. K., Reimherr, F. W., Wender, P. H., & Gift, T. E. (2015) · Annals of Clinical Psychiatry · doi:10.1177/104012371502700406 · Cited by 16
“…on combined data from a nonclinical community population and from 2 adult ADHD clinical trials, one using osmotic release oral system methylphenidate (OROS MPH) 18 and the other, a methylphenidate transdermal system (MTS), 19 as well as 11 clinical trials of treatment for anxiety or depression.”
InfluentialSelf-citationBrancati, G. E., Acierno, D., Barbuti, M., Elefante, C., Gemignani, S., Raia, A., & Perugi, G. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2263645 · Cited by 17
Gift, T. E., Reimherr, F. W., Marchant, B. K., Steans, T. A., & Wender, P. H. (2016) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000470 · Cited by 15
Self-citationDuygular ve Psikolojik Belirtiler Arasındaki İlişkiler
Vatan, S. (2017) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.281117 · Cited by 23
Elevated rates of ADHD in mothers of children with comorbid ADHD and epilepsy
Gonzalez–Heydrich, J., Hamoda, H. M., Luna, L. L., Rao, S., McClendon, J., Rotella, P., Waber, D. P., Boyer, K., Faraone, S. V., Whitney, J. E., et al. (2012) · Neuropsychiatry · doi:10.2217/npy.12.53 · Cited by 15
Genetic hypotheses for schizophrenia
Crow, T. J. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.2.180 · Cited by 15
Weibel, S., Bicego, F., Muller, S., Martz, E., Costache, M. E., Kraemer, C., Bertschy, G., Lopez, R., & Weiner, L. (2022) · Journal of Attention Disorders · doi:10.1177/10870547211027647 · Cited by 14
“Our study used the SR-WRAADDS, a self-report questionnaire used in several studies (Marchant et al., 2011, 2015; Reimherr et al., 2007).”
MethodEffects of perinatal methylphenidate (MPH) treatment in male and female Sprague–Dawley offspring
Panos, J., Law, C., & Ferguson, S. A. (2014) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2014.01.004 · Cited by 14
The Relationship Between Neuropsychological Deficits and Emotional Lability in Adults With ADHD
Gisbert, L., Richarte, V., Corrales, M., Ibáñez, P., Bosch, R., Bellina, M., Fadeuilhe, C., Casas, M., & Ramos‐Quiroga, J. A. (2018) · Journal of Attention Disorders · doi:10.1177/1087054718780323 · Cited by 15
Pharmacotherapy of ADHD in adults
Prince, J. B., Morrison, N. R., & Wilens, T. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139035491.023 · Cited by 22
Westover, A. N., Nakonezny, P. A., Winhusen, T. M., Adinoff, B. H., & Vongpatanasin, W. (2012) · Journal of Clinical Hypertension · doi:10.1111/jch.12039 · Cited by 11
Rösler, M. (2009) · Key issues in mental health (Online)/Key issues in mental health (Print) · doi:10.1159/000258454 · Cited by 13
Emotional dysregulation and stimulant medication in adult ADHD
Greenfield, M. S., Wang, Y., Hamilton, J. P., Thunberg, P., & Msghina, M. (2024) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.240009 · Cited by 14
Brancati, G. E., Rosa, U. D., Dominicis, F. D., Petrucci, A., Nannini, A., Medda, P., Schiavi, E., & Perugi, G. (2023) · Brain Sciences · doi:10.3390/brainsci13091251 · Cited by 10
Knouse, L. E., Sprich, S. E., Cooper‐Vince, C. E., & Safren, S. A. (2009) · PubMed · Cited by 12
Stimulants in Bipolar Disorder: Beyond Common Beliefs
Hensch, T., Himmerich, H., Hegerl, U., & McIntyre, R. S. (2010) · CNS Spectrums · doi:10.1017/s1092852900000390 · Cited by 9
Updates in Pharmacologic Strategies in Adult Attention-Deficit/Hyperactivity Disorder
Anbarasan, D., Safyer, G., & Adler, L. A. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.03.008 · Cited by 10
Sopko, M. A., Caberwal, H., & Chavez, B. (2010) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s4178 · Cited by 10
Emotional Intelligence as an Evolutive Factor on Adult With ADHD
Quintero, J., Vera, R., Morales, I., Zuluaga, P., & Fernández, A. (2017) · Journal of Attention Disorders · doi:10.1177/1087054716688251 · Cited by 13
Dikkat Eksikliği ve Hiperaktivite Bozukluğunda Duygu Düzenleme Güçlükleri ve Tedavisi
Öztürk, Y., Özyurt, G., Tufan, A. E., & Pekcanlar, A. A. (2018) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.358101 · Cited by 17
Huang, J., Mauche, N., Ahlers, E., Bogatsch, H., Böhme, P., Ethofer, T., Fallgatter, A. J., Gallinat, J., Hegerl, U., Heuser, I., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1294314 · Cited by 8
OROS methylphenidate hydrochloride for adult patients with attention deficit/hyperactivity disorder
McBurnett, K., & Starr, H. L. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.546058 · Cited by 8
Should we Keep on? Looking into Pharmacogenomics of ADHD in Adulthood from a Different Perspectives
Rovaris, D. L., Mota, N. R., da Silva, B. S., Girardi, P., Victor, M. M., Grevet, E. H., Bau, C. H. D., & Contini, V. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.95 · Cited by 10
Nadeau, J. M., McBride, N. M., Dane, B. F., Collier, A. B., Keene, A. C., Hacker, L. E., Cavitt, M. A., Alvaro, J. L., & Storch, E. A. (2015) · Journal of Child and Family Studies · doi:10.1007/s10826-015-0303-7 · Cited by 10
Dikkat Eksikliği Hiperaktivite Bozukluğunda Duygusal Zeka
Kaypaklı, G. Y., & Tamam, L. (2018) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.467037 · Cited by 9
Drug Class Review: Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder
McDonagh, M. S., & Peterson, K. (2011) · Cited by 7
ADHD in Adults: A Clinical Concern
Asherson, P. J. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-248-3_1 · Cited by 9
OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder
Ramos‐Quiroga, J. A., Corominas, M., Cervelló, X. C., Bosch, R., & Casas, M. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.65 · Cited by 7
Gibbins, C., & Weiss, M. D. (2009) · Current Attention Disorders Reports · doi:10.1007/s12618-009-0016-1 · Cited by 7
Brancati, G. E., Rosa, U. D., Magnesa, A., Dominicis, F. D., Petrucci, A., Schiavi, E., Medda, P., Barbuti, M., & Perugi, G. (2025) · Brain Sciences · doi:10.3390/brainsci15020182 · Cited by 6
Wyrwich, K. W., Shaffer, S., Gries, K. S., Auguste, P., Mooney, K. H., Prasad, S., & Bilder, D. A. (2016) · Journal of Inborn Errors of Metabolism and Screening · doi:10.1177/2326409816639316 · Cited by 6
Managing ADHD in Adults with Common Comorbidities
Sobanski, E., Paslakis, G., Schredl, M., Daffner, S., & Alm, B. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-248-3_8 · Cited by 7
ADHD and Bipolar Disorder: Common Causes Common Cure?
Hensch, T., Himmerich, H., & Hegerl, U. (2010) · Journal of Attention Disorders · doi:10.1177/1087054709357405 · Cited by 6
Adult Attention-Deficit Hyperactivity Disorder
Knouse, L. E., & Safren, S. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-387-5_9 · Cited by 3
Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial)
Zeng, L., Perin, J., Gross, A. L., Shade, D. M., Lanctôt, K. L., Lerner, A. J., Mintzer, J. E., Brawman‐Mintzer, O., Padala, P. R., van Dyck, C. H., et al. (2024) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.6108 · Cited by 4
Torgersen, T., Krokstad, S., & Vaaler, A. E. (2014) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0135-0 · Cited by 5
Assessment and Treatment of ADHD in Adults
Weiss, N. (2011) · Psychiatric Annals · doi:10.3928/00485713-20101221-05 · Cited by 4
The Art of Prescribing Pharmacological Management of Adult ADHD: Implications for Psychiatric Care
Antai-Otong, D. (2008) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.2008.00174.x · Cited by 5
An, Y., Song, Y., & Kang, U. G. (2022) · 신경정신의학 · doi:10.4306/jknpa.2022.61.2.45 · Cited by 3
Giri, D., López, J. H., Campos‐Castillo, C., & Marathe, M. (2025) · International ACM SIGACCESS Conference on Computers and Accessibility (ASSETS) · doi:10.1145/3663547.3746378 · Cited by 3
Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung im Erwachsenenalter
Sobanski, E., Alm, B., & Thome, J. (2015) · Springer eBooks · doi:10.1007/978-3-642-45028-0_85-1 · Cited by 2
Emotional Dysregulation in Adult ADHD
Adler, L. A., & Silverstein, M. J. (2018) · Psychiatric Annals · doi:10.3928/00485713-20180607-01 · Cited by 3
Can ayahuasca reduce inattention, hyperactivity and impulsivity? A pilot study
Tsang, W., Ruffell, S., Netzband, N., Jong, A., Rucker, J., Deeley, Q., & Hollingdale, J. (2023) · Drug Science Policy and Law · doi:10.1177/20503245231215413 · Cited by 1
Kılıç, B., Ünal, D., & Bingöl, M. E. (2025) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2025.5460 · Cited by 1
Comorbid Symptoms, Syndromes, and Disorders
UKAAN (2013) · doi:10.1007/978-1-908517-79-1_6 · Cited by 1
Silverstein, M. J., Alperin, S., Hochstein, Y., & Adler, L. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-64251-2_11 · Cited by 1
Efficacy of Amphetamines, Methylphenidate, and Modafinil in the Treatment of Mental Disorders
Retz, W. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_319 · Cited by 1
Stimulant treatment of adult ADHD
Spencer, T. J., & Biederman, J. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511780752.018 · Cited by 1
Villemonteix, T. (2015) · theses.fr (ABES) · doi:10.70675/84304c2az6a4fz488czbda7z8935968796d4 · Cited by 1
TDAH en adultos factores genéticos, evaluación y tratamiento farmacológico
Ramos‐Quiroga, J. A. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 9
Dige, N. (2010) · Figshare · Cited by 2
Neurocognitive deficits in adult ADHD : preclinical and clinical studies
Tomlinson, A. (2014) · Research Explorer (The University of Manchester) · Cited by 1
Anforderungen an die weitere Forschung
Hinkelmann, R. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-31585-5.00007-4
This Issue: Cases in Adult Attention-Deficit/Hyperactivity Disorder
Simon, A. B. (2013) · Psychiatric Annals · doi:10.3928/00485713-20130109-02
Sadek, J. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-39794-8_6
Heber, E. (2017) · CUNY Academic Works (City University of New York)
The Phenotypic Expression of ADHD in Adulthood
Pallanti, S., & Salerno, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-39051-8_3
Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung im Erwachsenenalter
Sobanski, E., Alm, B., & Thome, J. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_85 · Cited by 2
Efficacy of Amphetamines, Methylphenidate, and Modafinil in the Treatment of Mental Disorders
Retz, W. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_319-1
Current awareness in human psychopharmacology
(2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.796
Medications Affecting Behavior and Learning
Goldstein, S., Naglieri, J. A., & DeVries, M. L. (2011) · Wiley eBooks · doi:10.1002/9781118093085.ch18
Asherson, P. J., Stringaris, A. K., Chen, W., & Taylor, E. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.2.182
Brancati, G. E., Ventura, L., Froli, A., Gemignani, S., Gift, T. E., Marchant, B. K., & Perugi, G. (2025) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2025.100908 · Cited by 1
Self-citationLabilitat emocional en el trastorn per dèficit d'atenció i hiperactivitat
Gisbert, L., & Legal, U. A. D. B. D. D. P. I. D. M. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Roy, S., Veronesi, G. F., Mannarini, S., Pirolo, D., Bellato, A., Cortese, S., & Parlatini, V. (2026) · CNS Drugs · doi:10.1007/s40263-026-01323-7
Victor, M. M. (2014) · Lume (Universidade Federal do Rio Grande do Sul) · Cited by 3
Metadata
- Authors
- Reimherr, F. W., Williams, E. D., Strong, R. E., Mestas, R., Soni, P., & Marchant, B. K.
- Affiliations
- University of Utah (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-01-15
- Volume
- 68
- Issue
- 01
- Pages
- 93-101
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2025163293
- Cited by
- 180
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 2 · 2018: 7 · 2017: 11 · 2016: 9 · 2015: 12 · 2014: 15 · 2013: 11 · 2012: 16
- FWCI
- 10.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- adult ADHD, OROS methylphenidate, long-acting stimulants, oppositional defiant disorder, emotional dysregulation, emotional symptoms, inattention, hyperactivity/impulsivity, ADHD Rating Scale, treatment efficacy
- MeSH terms
- Administration, Oral, Adult, Affective Symptoms, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Delayed-Action Preparations, Double-Blind Method, Female, Humans, Male, Methylphenidate, Middle Aged, Osmosis, Treatment Outcome, Cross-Over Studies, Attention Deficit and Disruptive Behavior Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.